DNA Chip Research Inc. (TYO:2397)
1,090.00
-1.00 (-0.09%)
Jun 6, 2025, 2:36 PM JST
DNA Chip Research Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 410 | 388 | 275 | 489 | 620 | Upgrade
|
Cash & Short-Term Investments | 410 | 388 | 275 | 489 | 620 | Upgrade
|
Cash Growth | 5.67% | 41.09% | -43.76% | -21.13% | 105.30% | Upgrade
|
Accounts Receivable | 201 | 189 | 179 | 173 | 149 | Upgrade
|
Other Receivables | - | - | 26 | - | - | Upgrade
|
Receivables | 201 | 189 | 205 | 173 | 149 | Upgrade
|
Inventory | 46 | 67 | 18 | 8 | 3 | Upgrade
|
Prepaid Expenses | 12 | 14 | 19 | 37 | 49 | Upgrade
|
Other Current Assets | 9 | 19 | 8 | 3 | 3 | Upgrade
|
Total Current Assets | 678 | 677 | 525 | 710 | 824 | Upgrade
|
Property, Plant & Equipment | 132 | 107 | 113 | 2 | 17 | Upgrade
|
Long-Term Investments | 58 | 59 | 68 | 35 | 74 | Upgrade
|
Other Intangible Assets | 121 | 138 | 163 | 142 | 104 | Upgrade
|
Other Long-Term Assets | 2 | 1 | 2 | 1 | 1 | Upgrade
|
Total Assets | 991 | 982 | 871 | 890 | 1,020 | Upgrade
|
Accounts Payable | 64 | 70 | 55 | 47 | 50 | Upgrade
|
Accrued Expenses | 37 | 29 | 25 | 24 | 21 | Upgrade
|
Current Income Taxes Payable | 133 | 37 | 12 | 22 | 9 | Upgrade
|
Other Current Liabilities | 34 | 72 | 29 | 6 | 1 | Upgrade
|
Total Current Liabilities | 268 | 208 | 121 | 99 | 81 | Upgrade
|
Other Long-Term Liabilities | 35 | 30 | 30 | 2 | 2 | Upgrade
|
Total Liabilities | 317 | 250 | 161 | 111 | 91 | Upgrade
|
Common Stock | 927 | 927 | 792 | 642 | 642 | Upgrade
|
Additional Paid-In Capital | 955 | 955 | 820 | 670 | 670 | Upgrade
|
Retained Earnings | -1,208 | -1,150 | -901 | -539 | -405 | Upgrade
|
Comprehensive Income & Other | - | - | -1 | 6 | 22 | Upgrade
|
Shareholders' Equity | 674 | 732 | 710 | 779 | 929 | Upgrade
|
Total Liabilities & Equity | 991 | 982 | 871 | 890 | 1,020 | Upgrade
|
Net Cash (Debt) | 410 | 388 | 275 | 489 | 620 | Upgrade
|
Net Cash Growth | 5.67% | 41.09% | -43.76% | -21.13% | 105.30% | Upgrade
|
Net Cash Per Share | 60.64 | 61.05 | 46.87 | 84.46 | 109.22 | Upgrade
|
Filing Date Shares Outstanding | 6.76 | 6.37 | 6.05 | 5.79 | 5.79 | Upgrade
|
Total Common Shares Outstanding | 6.76 | 6.37 | 6.05 | 5.79 | 5.79 | Upgrade
|
Working Capital | 410 | 469 | 404 | 611 | 743 | Upgrade
|
Book Value Per Share | 99.70 | 114.95 | 117.30 | 134.55 | 160.52 | Upgrade
|
Tangible Book Value | 553 | 594 | 547 | 637 | 825 | Upgrade
|
Tangible Book Value Per Share | 81.80 | 93.28 | 90.37 | 110.03 | 142.55 | Upgrade
|
Order Backlog | - | 123 | 70 | 13 | 30 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.